Genomics England today (11 March 2015) announced the successful companies in its Small Business Research Initiative (SBRI) Phase Two assessment of Enabling Technologies for Genomics Sequence Data Analysis and Interpretation. £8 million is being made available for the product development stage of the competition with the companies adopting a programme of 12 to 24 months each.

This competition seeks development of technological innovations that will enhance genomic sequence data analysis capabilities. It is intended that this will support the development of new commercial products to develop the diagnostic potential of genomic screening and the wider use of stratified medicine in the UK and in world healthcare.

The successful companies are developing the following products:
Read more on Genomics England…